Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-07

Clinical Trial Update: Misoprostol for Reduction of Blood Loss During Fibroid Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating misoprostol to reduce blood loss during fibroid surgery was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Northwestern University | Conditions: Fibroids | Phase 4 | Status: TERMINATED | Results posted: 2023-09-07